Skip to Content
Skip to Content

Registry of CLH intentions until outcome

Registry of CLH intentions until outcome

The registry of classification and labelling (CLH) intentions until outcome lists the intentions and proposals received by ECHA for a new or revised harmonised classification and labelling of a substance. The proposals are submitted by Member State competent authorities, manufacturers, importers or downstream users.  

Interested parties can follow the progress of a proposal through the CLH process, from the notification of the intention to the adoption of the opinion of the Committee for Risk Assessment (RAC). The advance notice enables interested parties to plan and prepare for commenting later on.

Anyone with relevant information on the identity or hazard properties of a substance is encouraged to provide this information to the dossier submitter during the early stages of the process, or at the latest during the public consultation.

Where an opinion has been adopted by RAC, the status is indicated as ‘Opinion Adopted’.

Note: The classification tables for those substances that have been reviewed are listed in the ‘Corrigenda to the RAC opinions’ document.

reaction mass of 5-chloro-2-methyl-2<I>H</I>-isothiazol-3-one and 2-methyl-2H</I>-isothiazol-3-one (3:1)

EC / List no: 611-341-5 CAS no: 55965-84-9
CLP Annex VI Index number
613-167-00-5
Further substance information
Status
Opinion Adopted
Date of intention
09/03/2012
Expected date of submission
27/10/2014
Submitted for accordance check
17/10/2014
Final submission date
16/04/2015
Withdrawal date
Legal deadline for opinion adoption
14/10/2016
Submitter
France
Submitter's email
Harmonised classification at the time of the proposal
Acute Tox. 3*, H301
Acute Tox. 3*, H311
Acute Tox. 3*, H331
Skin Corr. 1B, H314
Skin Sens. 1, H317
Aquatic Acute 1, H400
Aquatic Chronic 1, H410
Specific concentration limits at the time of the proposal
Skin Corr. 1B; H314: C ≥ 0.6%
Skin Irrit. 2; H315: 0.06% ≤ C < 0.6%
Eye Irrit. 2; H319: 0.06% ≤ C < 0.6%
Skin Sens. 1; H317: C ≥ 0.0015%
Proposed harmonised classification by the dossier submitter
Acute Tox. 3, H301
Acute Tox. 2, H310
Acute Tox. 2, H330
Skin Corr. 1C, H314
Skin Irrit. 2, H315
Eye Irrit. 2, H319
Skin Sens. 1A, H317
Aquatic Acute 1, H400
Aquatic Acute 1, M-factor=100
Aquatic Chronic 1, H410
Aquatic Chronic 1, M-factor=100
Proposed specific concentration limits by the dossier submitter
Skin Corr. 1C; H314: C ≥ 0.5%
Skin Irrit. 2; H315: 0.06% ≤ C < 0.6%
Eye Irrit. 2; H319: 0.06% ≤ C < 0.6%
Skin Sens. 1A; H317: C ≥ 0.0015%
Regulatory programme
Active substance in Biocidal Products
Remarks
Start of consultation
10/07/2015
Deadline for commenting
24/08/2015
Hazard classes open for commenting
Acute Toxicity (inhalation and dermal)
Skin Corrosion
Skin Sensitisation
Environmental hazards
CLH report
Annexes to the CLH report
Date of opinion
10/03/2016
RAC Opinion
Background document
RCOM (Comments received)
Attachments received during public consultation (excluding journal articles)
Minority opinion(s)
Other annexes
ATP number and date
Link to ATP
Latest update
02/04/2019

Categories Display

Tagged as:

(click the tag to search for relevant content)


Route: .live1